Tata India Pharma & Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8352 Cr | ₹1282 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.82 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 0.21% | 1.03% |
6 Month | 0.8% | -0.82% |
1 Year | 11.79% | 11.03% |
3 Year | 24.39% | 23.9% |
5 Year | 21.92% | 21.85% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 6.54% | 5.59% |
1 Year | 6.93% | 4.7% |
3 Year | 23.39% | 23.65% |
5 Year | 19.28% | 19.43% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 17.67% | 9.47% |
3 Year | 20.32% | 18.04% |
5 Year | 20.52% | 14.89% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.75% | 15.93% |
Sharp | 1.20% | 1.09% |
Beta | 0.90% | 0.99% |
Alpha | 0.72% | -1.23% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Funds Managed | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.42 | 10.06 |
Large Cap | 36.54 | 27.56 |
Mid Cap | 31.26 | 32.77 |
Small Cap | 30.78 | 29.61 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.42 | 7.68 |
Healthcare | 98.58 | 89.02 |
Basic Materials | - | 2.34 |
Financial Services | - | 0.96 |
Top Comparisons
SBI Magnum Constant Maturity Fund - Regular Plan - Growth
3Y Returns8.78%
DSP 10Y G-Sec Fund - Regular Plan - Growth
3Y Returns8.73%
Canara Robeco Large Cap Fund - Regular Plan - Growth Option
3Y Returns18.33%
Sundaram Large Cap Fund Regular Plan - Growth
3Y Returns15.55%
Nippon India Arbitrage Fund - Growth Plan - Growth Option
3Y Returns6.77%
HSBC Arbitrage Fund - Regular Growth
3Y Returns6.72%
LIC MF Money Market Fund Regular - Growth
3Y Returns0%
HSBC Money Market Fund - Regular Growth
3Y Returns7.12%